KTTA
PASITHEA THERAP (KTTA)
NASDAQ
$0.56+$0.02 (+3.92%)
Price as of Jun 23, 2026 7:51 PM EDT
  • $18.0M
    Market Cap
  • -25.08%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
486,559
+3,130.37%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
113,195
+555.25%
Gross Profit
0
N/A
0
N/A
0
-100.00%
373,364
+16,971.40%
Sales and Marketing Expense
N/A
N/A
7.1M
-10.50%
7.9M
-37.09%
12.5M
+178.00%
Research and Development Expense
-8.0M
+10.87%
-7.2M
-11.14%
-8.1M
+203.92%
-2.7M
N/A
Depreciation and Amortization Expense
32,421
+71.86%
18,865
+3.14%
18,290
-41.97%
31,520
+2,185.71%
Total Operating Expenses
12.9M
+82.60%
7.1M
-10.50%
7.9M
+6,860.20%
113,195
+555.25%
Operating Profit
-20.9M
+46.37%
-14.2M
-10.82%
-16.0M
+7.85%
-14.8M
+228.71%
Interest Income
327,193
-22.68%
423,184
+1.88%
415,368
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-102
-79.92%
Interest Income and Expense and Net
327,193
-22.68%
423,184
+1.88%
415,368
+407,323.53%
-102
-79.92%
Total Nonoperating Income and Expense
429,612
+24.39%
345,378
-26.77%
471,613
+462,265.69%
102
-100.00%
Income before Taxes
-20.4M
+46.91%
-13.9M
-10.34%
-15.5M
+11.27%
-13.9M
+541.19%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
4.2M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-20.4M
+46.91%
-13.9M
-12.89%
-16.0M
+14.53%
-13.9M
+541.19%
Net Income from Continuing Operations Applicable to Common
-20.4M
+46.91%
-13.9M
-10.34%
-15.5M
+11.27%
-13.9M
+541.19%
Basic EPS and Net Income
-2.91
N/A
N/A
N/A
-0.42
-23.64%
-0.55
+161.90%
Diluted EPS and Net Income
-2.91
N/A
N/A
N/A
-0.42
-23.64%
-0.55
+161.90%
Basic Weighted Average Shares
7.0M
+541.47%
1.1M
-10.64%
1.2M
-95.14%
25.3M
+142.70%
Diluted Weighted Average Shares
7.0M
+541.47%
1.1M
-10.64%
1.2M
-95.14%
25.3M
+142.70%
Balance Sheet
Cash and Cash Equivalents
55.2M
+696.78%
6.9M
-57.61%
16.3M
-50.73%
33.1M
-37.42%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
55.2M
+696.78%
6.9M
-57.61%
16.3M
-50.73%
33.1M
-37.42%
Total Current Assets
56.5M
+666.24%
7.4M
-55.86%
16.7M
-51.02%
34.1M
-36.07%
Accumulated Depreciation
2,500
-94.10%
42,353
+80.32%
23,488
N/A
N/A
N/A
Property and Plant and Equipment and Net
11,000
-91.01%
122,343
-13.36%
141,208
-62.72%
378,783
+1,782.25%
Total Long-Term Assets
11,000
-91.01%
122,343
-13.36%
141,208
-62.72%
378,783
+1,782.25%
Total Assets
60.2M
+274.98%
16.1M
-38.49%
26.1M
-42.19%
45.2M
-15.27%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.0M
+344.15%
1.1M
-57.48%
2.6M
+40.29%
1.9M
+319.79%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
46,871
-71.10%
162,172
+92.22%
84,366
-89.51%
804,207
-44.64%
Total Liabilities
5.0M
+291.63%
1.3M
-52.84%
2.7M
+1.36%
2.7M
+41.14%
Retained Earnings
-70.0M
+41.20%
-49.6M
+40.39%
-35.3M
+82.46%
-19.4M
+774.10%
Total Stockholders Equity
55.2M
+273.54%
14.8M
-36.82%
23.4M
-44.94%
42.5M
-17.35%
Total Shares Outstanding
23.1M
+1,556.15%
1.4M
+33.86%
1.0M
-96.00%
26.0M
+13.19%
Cash Flow
Cash from Operating Activities
-15.2M
+9.25%
-13.9M
+3.71%
-13.4M
-7.80%
-14.6M
+358.78%
Capital Expenditures
N/A
N/A
N/A
N/A
34,301
-90.85%
374,889
+1,643.43%
Cash from Investing Activities
11,000
N/A
0
-100.00%
399,006
+119.35%
-2.1M
+9,487.25%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
63.5M
+1,306.02%
4.5M
+221.23%
-3.7M
+16.22%
-3.2M
-105.73%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
76.74%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-3,045.12%
N/A
Return on Assets
-53.54%
-18.79%
-65.93%
+47.24%
-44.78%
+58.23%
-28.30%
N/A
Return on Equity
-58.36%
-19.87%
-72.83%
+50.35%
-48.44%
+63.24%
-29.68%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
3,130.37%
N/A
Current Ratio
11.35
+72.52%
6.58
+3.83%
6.34
-65.08%
18.15
N/A
Cash Ratio
11.09
+79.39%
6.18
-0.30%
6.20
-64.88%
17.65
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow